ARCHIVES

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

This article is from The Cancer Letter archive.

Vol. 21 No. 42 | November 3, 1995

Download PDF Visit The Full Archive

Related Articles

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Suitable Mechanism, Funding Source Were Issues In diet FIT

December 15, 1989

Non-Caucasians At Higher Risk For Severe Breast Cancer Pain

December 28, 2007

Breast Cancer Activist, Radiologist Are Added To Special Commission

November 6, 1992

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989